A Bayesian model for evaluating specificity of treatment effects in clinical trials.
Simon
R M
RM
Biometrics Research Branch, National Cancer Institute (NCI), Bethesda, MD 20892, USA.
Dixon
D O
DO
Freidlin
B
B
D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy; D001499:Bayes Theorem; D002986:Clinical Trials as Topic; D006801:Humans; D016016:Proportional Hazards Models